Abstract:The goal of this study is to explore the role of the LMNB1 gene in glioma. A cohort of 160 patients who underwent glioma surgery were randomly selected of this study. The LMNB1 expression was assessed employing immunohistochemical and real-time quantitative polymerase chain reaction methods. Initially, RNA interference technology was applied to suppress gene expression, followed by the evaluation of tumor cell proliferation, apoptosis, cell cycle dynamics, and migration. The underlying molecular mechanisms of LMNB1 function were examined by a human phospho-kinase array and immunoblotting. And we established the xenograft models to determine the effect of tumor growth as well as the degree of invasion in shLMNB1 mice. Elevated LMNB1 expression correlated with unfavorable overall survival and disease-free survival. A substantial inhibition in cell growth was observed subsequent to LMNB1 knockdown in SHG-44 and U251 glioma cells. SHG-44-shLMNB1 cells exhibited a reduction in the S phase population, along with an increase in cells in G1 and G2 phases. Similarly, shLMNB1 U251 cells showed fewer cells in the S phase and an elevation in cells in G1 phase. Notably, increased apoptosis was observed in U251-shLMNB1 cells and SHG-44-shLMNB1 cells. Wound healing and Transwell migration assays demonstrated a significant decrease in the migration rate of both SHG-44-shLMNB1 and U251-shLMNB1 cells. The phosphorylation levels of Akt1/2/3, as well as the expressions of PI3K, AKT, and p-AKT proteins, were reduced in the shLMNB1 group. Downregulation of LMNB1 repressed tumor progress in vivo. The silencing of LMNB1 was found to significantly reduce the proliferation of human glioma cells, induce apoptosis in tumor cells, impede the progression of the cell cycle, and inhibit the migration of tumor cells. Consequently, we hypothesize that LMNB1 promotes glioma cell proliferation through mechanisms involving the inhibition of tumor cell apoptosis, acceleration of the cell cycle, and enhancement of tumor cell migration. We found that LMNB1 exert critical roles in glioma progression may via regulation of PI3K/Akt signaling pathway. These observations suggest that LMNB1 holds clinical potential for diagnostic and prognostic applications in glioma, presenting novel targets for drug development.

LAP3 Promotes Glioma Progression by Regulating Proliferation, Migration and Invasion of Glioma Cells

Long Non‑coding RNA LINC00473/miR‑195‑5p Promotes Glioma Progression Via YAP1‑TEAD1‑Hippo Signaling.

Leucine aminopeptidase 3 promotes migration and invasion of breast cancer cells through upregulation of fascin and matrix metalloproteinases‐2/9 expression

Overexpression of Leucine Aminopeptidase 3 Contributes to Malignant Development of Human Esophageal Squamous Cell Carcinoma

NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

The 37-Kda Laminin Receptor Precursor Regulates the Malignancy of Human Glioma Cells.

LASP1 Promotes Glioma Cell Proliferation and Migration and is Negatively Regulated by Mir-377-3p

LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma

Inhibition of Leucine Aminopeptidase 3 Suppresses Invasion of Ovarian Cancer Cells Through Down-Regulation of Fascin and MMP-2/9.

Clinical Significance of Angiopoietin-Like Protein 3 Expression in Patients with Glioblastoma

PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways

[LRIG3 Gene Regulates Biological Activity of GL15 Cell Line].

GSK-3 beta regulates tumor growth and angiogenesis in human glioma cells

A pan-cancer analysis of prognostic significance and immunological role of lysosomal-associated membrane protein 3

Pan-Cancer Analysis of LAP2α As a Potential Prognostic and Immunological Biomarker for Multiple Cancer Types Including Glioma

The Expression of ASAP3 and NOTCH3 and the Clinicopathological Characteristics of Adult Glioma Patients

Chaperone-mediated Autophagy Regulates Cell Growth by Targeting SMAD3 in Glioma

Impact of Nuclear Peripheral Chromatin Lamin LMNB1 Gene in the Proliferation and Migration of Glioma Cells

Long Non-Coding RNA LINC01503 Predicts Worse Prognosis in Glioma and Promotes Tumorigenesis and Progression Through Activation of Wnt/β-catenin Signaling.

STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYC